Betaine Hydrochloride Market Scenario 2020-2027:

The Global Betaine Hydrochloride Market exhibits comprehensive information that is a valuable source of insightful data for business strategists during the decade 2014-2027. On the basis of historical data, Betaine Hydrochloride Market report provides key segments and their sub-segments, revenue and demand & supply data. Considering technological breakthroughs of the market Betaine Hydrochloride industry is likely to appear as a commendable platform for emerging Betaine Hydrochloride Market investors.

This Betaine Hydrochloride Market Report covers the manufacturers data, including shipment, price, revenue, gross profit, interview record, business distribution, etc., these data help the consumer know about the competitors better.

Get Sample Report: https://grandviewreport.com/sample/30934

The complete value chain and downstream and upstream essentials are scrutinized in this report. Essential trends like globalization, growth progress boost fragmentation regulation & ecological concerns. This Market report covers technical data, manufacturing plants analysis, and raw material sources analysis of Betaine Hydrochloride Industry as well as explains which product has the highest penetration, their profit margins, and R&D status. The report makes future projections based on the analysis of the subdivision of the market which includes the global market size by product category, end-user application, and various regions.

Topmost Leading Manufacturer Covered in this report:Shandong Ruihong Biotechnology, Hebei Kangdali Pharmaceutical, Sunwin Biotech Shandong, Shaanxi Fuheng (FH) Biotechnology, Shanghai Freemen, Shandong Grand Biotechnology

Product Segment Analysis: 0.985, 0.98, Other

Application Segment Analysis:Feed Industry, Pharmaceuticals Industry, Other

Get Discount @ https://grandviewreport.com/discount/30934

Regional Analysis For Betaine Hydrochloride Market

North America(the United States, Canada, and Mexico)Europe(Germany, France, UK, Russia, and Italy)Asia-Pacific(China, Japan, Korea, India, and Southeast Asia)South America(Brazil, Argentina, Colombia, etc.)The Middle East and Africa(Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

Market Synopsis:The market research report consists of extensive primary research, as well as an in-depth analysis of the qualitative and quantitative aspects by various industry specialists and professionals, to gain a deeper insight into the market and the overall landscape.

The objectives of the report are:

To analyze and forecast the market size of Betaine Hydrochloride Industry in theglobal market. To study the global key players, SWOT analysis, value and global market share for leading players. To determine, explain and forecast the market by type, end use, and region. To analyze the market potential and advantage, opportunity and challenge, restraints and risks of global key regions. To find out significant trends and factors driving or restraining the market growth. To analyze the opportunities in the market for stakeholders by identifying the high growth segments. To critically analyze each submarket in terms of individual growth trend and their contribution to the market. To understand competitive developments such as agreements, expansions, new product launches, and possessions in the market. To strategically outline the key players and comprehensively analyze their growth strategies.

View Full Report @ https://grandviewreport.com/industry-growth/Betaine-Hydrochloride-Market-30934

At last, the study gives out details about the major challenges that are going to impact market growth. They also report provides comprehensive details about the business opportunities to key stakeholders to grow their business and raise revenues in the precise verticals. The report will aid the companys existing or intend to join in this market to analyze the various aspects of this domain before investing or expanding their business in the Betaine Hydrochloride Markets.

Contact Us:Grand View Report(UK) +44-208-133-9198(APAC) +91-73789-80300Email : [emailprotected]

Read the original post:
Betaine Hydrochloride Market: Qualitative analysis of the leading players and competitive industry scenario | Shandong Ruihong Biotechnology, Hebei...

Medical imaging plays a prominent role in clinical trials as it can help in providing answers to the critical challenges that occur in drug development process. It takes about 15 years for a drug to move from a laboratory set-up to FDA approval. The chances of a compound getting regulatory approval are minimal as out of 6 to 11,000 compounds that are evaluated in the pre-clinical stage, only 5 are able to make it to the clinical trials and only one of them gets regulatory approval. Medical imaging can help play a crucial role in the product development process as it can reduce the late-stage attrition by gathering more information in the pre-clinical trials of safety, efficacy, and mechanism of action.

Medical imaging applications for pharmaceutical clinical trials include identifying disease predisposition, diagnosing and evaluating lesions and their severity, determining the responder patients, and monitoring therapy effects and their follow-ups. Nuclear imaging techniques such as positron emission tomography (PET) are used to observe drug pharmacokinetics and distribution along with studying the specific molecular endpoints. For drug efficacy studies, use of imaging surrogate endpoints and imaging biomarkers can provide quick results with good statistical power as they help in facilitating small group sizes. In addition, imaging has a huge potential in drug safety assessment during clinical trials in the absence of suitable biomarker. With its widespread applications, medical imaging is witnessing a rapid growth in its use for clinical trials. In fact, medical imaging is used as an endpoint for about half of all clinical trials.

Request Brochure of Report https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20354

Factors that are driving the growth of the global clinical trial imaging market are increase in the biotechnology and pharmaceutical industries, rise in the number of contract manufacturing/contract research organizations, and an overall increase in research and development spending. Furthermore, the increasing prevalence of chronic diseases, portability and miniaturization of equipment, and rise in geriatric population are fueling the growth of the market. On the other hand, high cost of installation of these systems and enormous cost of clinical trials are projected to impede the growth of the market. However, the rise in demand for multimodal imaging systems and the growth potential offered by the emerging markets are projected to further boost the growth of the market during the forecast period.

Request for Analysis of COVID-19 Impact on Clinical Trial Imaging Market https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=20354

The global clinical trial imaging market is segmented into product, end-user, modality, and geography. In terms of product, the market is classified into software and services. The services segment is expected to have a significant share of the market owing to high costs associated with the imaging equipment. The biotechnology and pharmaceutical companies have been forced to outsource imaging clinical trials to service providers owing to the high cost. In terms of modality, the market is divided into PET, MRI, ultrasound, CT, X-Ray, and ECHO. The CT segment is projected to dominate the market. Based on end-user, the market is segmented into biotechnology companies, pharmaceutical companies, contract research organizations, medical device manufacturers, government research and academic institutes, skincare companies, and others. Pharmaceutical companies are projected to account for a prime share of the market.

Request for Custom Research https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=20354

In terms of geography, the global clinical trial imaging market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the market in terms of size owing to presence of large number of biotechnology and pharmaceutical companies, large R&D spending, and rise in number of contract research organizations (CROs). North America is followed by Europe. The market in Asia Pacific is expected to register a fast growth due to rapid advancements in the health care infrastructure and rise in prevalence of chronic diseases.

The major prominent players operating in the clinical trial imaging market are Cardiovascular Imaging Technologies LLC, Intrinsic Imaging, LLC, PAREXEL International Corporation, BioClinica, Inc, ICON plc, Biomedical Systems, IXICO PLC, WorldCare Clinical, LLC, and VirtualScopics Inc.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers or customers journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Pre Book Clinical Trial Imaging Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=20354&ltype=S

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

Mr. Rohit BhiseyTransparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY 12207

United States

USA Canada Toll Free: 866-552-3453

Email: [emailprotected]

Website: https://www.transparencymarketresearch.com/

Go here to read the rest:
Clinical Trial Imaging Market: Increase in the biotechnology and pharmaceutical industries is fueling the growth of the market - PRnews Leader

BOSTON, Oct. 30, 2020 /PRNewswire/ --908 Devices, a pioneer of purpose-built handheld and desktop Mass Spec devices for chemical and biomolecular analysis, today announced the appointment of Kevin Hrusovsky as the Chairman of its Board of Directors. Mr. Hrusovsky, who has served on the 908 Devices Board of Directors since 2013, is a biotech entrepreneur and healthcare visionary with a passion for revolutionizing healthcare and a proven track record of commercializing disruptive technologies.

"Our devices are used by our customers who need answers quickly, at the point-of-need to interrogate the unknown-and-invisible and provide actionable answers to address some of the most critical problems in life sciences research, bioprocessing, industrial biotech, and forensics." said Dr. Kevin J. Knopp, CEO and Co-Founder of 908 Devices. "Kevin Hrusovsky's deep knowledge and experience are incredibly additive as we democratize laboratory Mass Spectrometry instruments with our simple handheld and desktop devices."

"There has never been a more important time in science to harness advanced analytical tools," said Mr. Hrusovsky. "I'm honored to be named Chairman and committed to supporting technologies that accelerate outcomes and disrupt healthcare. Kevin Knopp and the 908 Devices team are democratizing Mass Spectrometry at an important inflection point for next generation Proteomics and its promise to revolutionize healthcare."

Kevin Hrusovsky currently serves as the Chairman, CEO and President of Quanterix (NASDAQ: QTRX), a company digitizing biomarker analysis to advance precision health. He is also the founder of Powering Precision Health (PPH) foundation, a non-profit global think tank composed of the industry's top medical, research and financial experts. Through his non-profit network and the power of Quanterix's disruptive Simoa technology, Mr. Hrusovsky is accelerating critical advances across neurology, oncology, infectious disease, cardiology, and inflammation.

A dynamic and respected thought leader, Hrusovsky is regularly sought after by mainstream media, including CBS, NBC, CNN, and other major news outlets to speak on the promise of precision health todiagnose diseases before symptoms even occur. Most recently, Mr. Hrusovsky spearheaded a newly formed Emergency COVID-19 Diagnostic & Drug PPH Advisory Panel that aims to enhance global understanding of COVID-19, including the innate and adaptive immune response to drive earlier intervention in the disease cascade, deliver more targeted therapeutic responses, and accelerate development of emerging drugs and vaccines.

About 908 DevicesWe make point-of-need-devices ranging from rugged, handheld chemical detection tools to compact, tiny footprint desktop analyzers. These uncomplicated purpose-built devices provide users with the power to redefine their workflows by getting actionable answers at the point of need. Our devices are being used for critical applications across the globe in life science research, bioprocessing, industrial biotech, forensics and adjacent markets. 908 Devices is headquartered in the heart ofBoston, where we research, design and manufacture innovative products that bring togetherhigh-pressure mass spectrometry(HPMS), microfluidic separations, software automation, and machine learning. For more information, visitwww.908devices.com.

SOURCE 908 Devices

Home

Original post:
908 Devices Names Kevin Hrusovsky, 30-year Biotechnology Veteran and Founder of Powering Precision Health, as Chairman of its Board of Directors -...

Impact of COVID-19 Global Agriculture Biotechnology Market Size, Status and Forecast 2020-2026

This report studies theAgriculture Biotechnologymarket with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Agriculture Biotechnology market analysis segmented by companies, region, type and applications in the report.

New vendors in the market are facing tough competition from established international vendors as they struggle with technological innovations, reliability and quality issues. The report will answer questions about the current market developments and the scope of competition, opportunity cost and more.

The major players covered in Agriculture Biotechnology Markets: ADAMA Agricultural Solutions, Vilmorin, Bayer, Biocentury Transgene, Certis, DowDuPont, Eurofins, Evogene, Global Bio-chem Technology, Syngenta, KWS Saat, Marina Biotech, Monsanto, and more

The final report will add the analysis of the Impact of Covid-19 in this report Agriculture Biotechnology industry.

Get a Sample Copy @ https://www.reportsandmarkets.com/sample-request/global-agriculture-biotechnology-market-size-status-and-forecast-2019-2025?utm_source=eurowire&utm_medium=42

Agriculture BiotechnologyMarket continues to evolve and expand in terms of the number of companies, products, and applications that illustrates the growth perspectives. The report also covers the list of Product range and Applications with SWOT analysis, CAGR value, further adding the essential business analytics. Agriculture Biotechnology Market research analysis identifies the latest trends and primary factors responsible for market growth enabling the Organizations to flourish with much exposure to the markets.

This report focuses on the globalAgriculture Biotechnologystatus, future forecast, growth opportunity, key market and key players. The study objectives are to present the Agriculture Biotechnology development inUnited States, Europe, China, Japan, Southeast Asia, India, and Central & South America.

Market segment by Type, the product can be split into

Market segment by Application, split into

Research Objectives:

TheAgriculture Biotechnologymarket research report completely covers the vital statistics of the capacity, production, value, cost/profit, supply/demand import/export, further divided by company and country, and by application/type for best possible updated data representation in the figures, tables, pie chart, and graphs. These data representations provide predictive data regarding the future estimations for convincing market growth. The detailed and comprehensive knowledge about our publishers makes us out of the box in case of market analysis.

Key questions answered in the report include:

Table of Contents

Chapter 1:GlobalAgriculture BiotechnologyMarket Overview

Chapter 2:Agriculture Biotechnology Market Data Analysis

Chapter 3:Agriculture Biotechnology Technical Data Analysis

Chapter 4:Agriculture Biotechnology Government Policy and News

Chapter 5:Global Agriculture Biotechnology Market Manufacturing Process and Cost Structure

Chapter 6:Agriculture Biotechnology Productions Supply Sales Demand Market Status and Forecast

Chapter 7:Agriculture Biotechnology Key Manufacturers

Chapter 8:Up and Down Stream Industry Analysis

Chapter 9:Marketing Strategy -Agriculture Biotechnology Analysis

Chapter 10:Agriculture Biotechnology Development Trend Analysis

Chapter 11:Global Agriculture Biotechnology Market New Project Investment Feasibility Analysis

Inquire More about This Report @ https://www.reportsandmarkets.com/enquiry/global-agriculture-biotechnology-market-size-status-and-forecast-2019-2025?utm_source=eurowire&utm_medium=42

About Us:

Reports and Marketsis not just another company in this domain but is a part of a veteran group calledAlgoro Research Consultants Pvt. Ltd. It offers premium progressive statistical surveying, market research reports, analysis & forecast data for a wide range of sectors both for the government and private agencies all across the world. The database of the company is updated on a daily basis. Our database contains a variety of industry verticals that include: Food Beverage, Automotive, Chemicals and Energy, IT & Telecom, Consumer, Healthcare, and many more. Each and every report goes through the appropriate research methodology, Checked from the professionals and analysts.

Contact Us:

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

View post:
Agriculture Biotechnology Industry Research Report, Growth Trends and Competitive Analysis 2020-2027: ADAMA Agricultural Solutions, Vilmorin, Bayer,...

The proposed Pre-Loaded Intraocular Lens Market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed analysis of market drivers, restraints, technological advancements & competitive landscape along with various micro & macro factors influencing the market dynamics.

The Pre-Loaded Intraocular Lens Market sample report includes an exclusive analysis of COVID-19 pandemic on the market space under scrutiny. The sample represents the format of the overall study which is designed to provide clarity on the structure of the report and some data points demonstrated in an attempt to provide insights into the study quality.

Furthermore, the Pre-Loaded Intraocular Lens Market full research study is designed on account of the fact that each segment is individually assessed and then collated to form the whole market, the study can be tailor-made to fit your exact requirements.

Request Sample Pages of this research study at https://www.theinsightpartners.com/sample/TIPRE00015245/

The structure of the Pre-Loaded Intraocular Lens Market report can be categorized into following sections:

The Prominent/Emerging Players in the Pre-Loaded Intraocular Lens Market Research include:

The Pre-Loaded Intraocular Lens Market Company Profiles are individually represented for all major participants and indices such as Financial Performance, Strategic Initiatives, Product Portfolio & Company Overview.

Company Overview:

Company overview provides the information about location of the company where it is headquartered along with the established year, employee strength as of 2017, regions where the company is operating and the key business areas.

Financial Performance:

Overall company/segment revenue for the year 2019, 2018, and 2017 is provided in the sub title Financial Performance (public listed companies) along with the analysis and explanation of the increase or decrease in the same due to factors such as mergers & acquisition, profit or loss in any strategic business unit (SBUs) and others.

Product Benchmarking:

Product benchmarking comprises the comprehensive list of products pertaining to the respective market along with the application and key features.

Strategic Initiatives:

Insights pertaining to the new product launch, strategic collaboration, mergers and acquisition, regulatory approval, and other developments by the company in market are covered under strategic initiatives section.

Order a copy of this research study at https://www.theinsightpartners.com/buy/TIPRE00015245/

The Pre-Loaded Intraocular Lens Market research study is designed keeping in focus all the major countries. Although, all these countries & their market trends were accounted for while composing it, detailed sections are available for only the spearheads. In case if you would be interested in specific countries which are not covered in the current scope, kindly share the list & we can customize the study based on the geographical scope defined by you.

ABOUT US:

The Insight Partners is a one stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Our research model is very simple. We believe in client servicing and delivering best quality to our customers. Through our research content, we are making sure that our customers get value of their money along with better quality data and analysis.

Our research content is majorly focused towards market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis etc. We provide detailed break-up of segmentation in terms of geography, technology, product and services etc.; which helps our clients to get a deeper analysis on various research topics.About Us:

Contact US:

If you have any queries about this report or would like further information, please contact us:

North America: +1 646 491 9876

Asia-Pacific: +91 20 6727 8686

Email: [emailprotected]

Read the original post:
Stem Cells in Regenerative Medicine: The Next Frontier in Biotechnology - The Think Curiouser

The 52 rating InvestorsObserver gives to Nantkwest Inc (NK) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 55 percent of stocks in the Biotechnology industry, NKs 52 overall rating means the stock scores better than 52 percent of all stocks.

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.

These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

Nantkwest Inc (NK) stock is trading at $9.27 as of 2:09 PM on Wednesday, Oct 14, a drop of -$0.17, or -1.8% from the previous closing price of $9.44. The stock has traded between $9.13 and $9.94 so far today. Volume today is 859,449 compared to average volume of 1,111,019.

Click Here to get the full Stock Score Report on Nantkwest Inc (NK) Stock.

See the original post here:
Is Nantkwest Inc (NK) The Right Choice in Biotechnology? - InvestorsObserver

This report also researches and evaluates the impact of Covid-19 outbreak on the Marine Biotechnology industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Marine Biotechnology and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Global Marine Biotechnology Market Overview:

The research report, titled [Global Marine Biotechnology Market 2020 by Company, Regions, Type and Application, Forecast to 2025], presents a detailed analysis of the drivers and restraints impacting the overall market. Analysts have studied the key trends defining the trajectory of the market. The research report also includes an assessment of the achievements made by the players in the global Marine Biotechnology market so far. It also notes the key trends in the market that are likely to be lucrative. The research report aims to provide an unbiased and a comprehensive outlook of the global Marine Biotechnology market to the readers.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.researchmoz.com/enquiry.php?type=S&repid=2609416&source=atm

Global Marine Biotechnology Market: Segmentation

For clearer understanding of the global Marine Biotechnology market, analysts have segmented the market. The segmentation has been done on the basis of application, technology, and users. Each segment has been further explained with the help of graphs figures. This breakdown of the market gives the readers an objective view of the global Marine Biotechnology market, which is essential to make sound investments.

The major players profiled in this report include:Aker BioMarineBASFCP KelcoCyanotech Lonza Group

To understand the changing political scenario, analysts have regionally segmented the market. This gives an overview of the political and socio-economic status of the regions that is expected to impact the market dynamic.

Global Marine Biotechnology Market: Research Methodology

To begin with, the analysis has been put together using primary and secondary research methodologies. The information has been authenticated by market expert through valuable commentary. Research analysts have also conducted exhaustive interviews with market-relevant questions to collate this research report.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2609416&source=atm

Global Marine Biotechnology Market: Competitive Rivalry

The research report also studied the key players operating in the global Marine Biotechnology market. It has evaluated and elucidated the research and development statuses of these companies, their financial outlooks, and their expansion plans for the forecast period. In addition, the research report also includes the list of strategic initiatives that clearly explain the achievements of the companies in the recent past.

The end users/applications and product categories analysis:On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-General Type

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Marine Biotechnology for each application, including-Marine

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2609416&licType=S&source=atm

Strategic Points Covered in TOC:

Chapter 1: Introduction, market driving force product scope, market risk, market overview, and market opportunities of the global Marine Biotechnology market

Chapter 2: Evaluating the leading manufacturers of the global Marine Biotechnology market which consists of its revenue, sales, and price of the products

Chapter 3: Displaying the competitive nature among key manufacturers, with market share, revenue, and sales

Chapter 4: Presenting global Marine Biotechnology market by regions, market share and with revenue and sales for the projected period

Chapter 5, 6, 7, 8 and 9: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions

Contact Us:

ResearchMoz

Tel: +1-518-621-2074

USA-Canada Toll Free: 866-997-4948

Email: [emailprotected]

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfil all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organisations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Read the rest here:
Marine Biotechnology Market 10-year Forecast and Trends Analysis Research Report - The Think Curiouser

');},success: function(response) {$('.megamenuthird[data-menu=' + $data_megamenu + '-articles]').html(response);},error: function(xhr) { // if error occured$('.megamenuthird[data-menu=' + $data_megamenu + '-articles]').html("Error occured.please try again"); }});}}//Child Level Menu Hoverfunction get_childlevelmenu(currentid){//console.log('current id '+currentid);var $currentelement = $('#'+currentid);$('.menu-item-'+$('#'+currentid).closest('.themegamenu').attr('cid').split('-')[3]).removeClass('defaultajax-1');var $data_menu = $('#'+currentid).closest('li').data('menu');var ajaxreplaceContent = $('#'+currentid).closest('.themegamenu').data('megamenu')+'-articles';var submenu = $data_menu.split('-');var data_menu_class=submenu[0];//$('.megamenuthird').empty();$('.megamenuthird[data-menu=' + ajaxreplaceContent + ']').empty();$('li.level_2').removeClass('activeli');$currentelement.closest('li').siblings().removeClass('activeli');$currentelement.closest('li').addClass('activeli');var current_megamenu_second = $('.megamenusecond[data-menu='+$data_menu+']').length;$('.megamenuopen .megamenusecond').removeClass('megamenusecond-show');//$currentelement.closest('li').find('.megamenuopen .megamenusecond').removeClass('megamenusecond-show');$('.megamenusecond[data-menu=' + $data_menu + ']').addClass('megamenusecond-show');//if(current_megamenu_seconda').html();/********* End level3 checking menu ********/// checking 4th level menu /*** 4th level Objec code here **///getting parent data-menuvar levelfour_data_menu = $('.megamenusecond[data-menu='+$data_menu+']').find('li.level_3.activeli').data('menu');// End getting parent data-menuvar subofSubChildLevel_cat_id = $('.megamenusecond[data-menu='+levelfour_data_menu+']').find('li.level_4.activeli').data('cat');var subofSubChildLevel_data_menu = $('.megamenusecond[data-menu='+levelfour_data_menu+']').find('li.level_4.activeli').data('menu');var subofSubChildLevel_taxnomy_type= $('.megamenusecond[data-menu='+levelfour_data_menu+']').find('li.level_4.activeli').data('type');var subofSubChildLevel_title = $('.megamenusecond[data-menu='+levelfour_data_menu+']').find('li.level_4.activeli>a').html();if(subofSubChildLevel_title!=''){var ajx_title=subofSubChildLevel_title;}else{var ajx_title=subChildLevel_title;}/*** End 4th level Objec code here **/if(subofSubChildLevel_cat_id!=''){var data_obj ={'title':ajx_title,'subofSubChildLevel_cat_id':subofSubChildLevel_cat_id,'subofSubChildLevel_taxnomy_type':subofSubChildLevel_taxnomy_type,'subChildLevel_cat_id': subChildLevel_cat_id,'subChildLevel_taxnomy_type' :subChildLevel_taxnomy_type,'ChildLevel_data_type':ChildLevel_data_type,'ChildLevel_data_cat_id':ChildLevel_data_cat_id,'parent_data_cat_id':parent_data_cat_id,'parent_data_type':parent_data_type};}else{var data_obj ={'title':ajx_title,'subChildLevel_cat_id': subChildLevel_cat_id,'subChildLevel_taxnomy_type' :subChildLevel_taxnomy_type,'ChildLevel_data_type':ChildLevel_data_type,'ChildLevel_data_cat_id':ChildLevel_data_cat_id,'parent_data_cat_id':parent_data_cat_id,'parent_data_type':parent_data_type};}} if( ajaxRequestProject != null ) {ajaxRequestProject.abort();ajaxRequestProject = null;}ajaxRequestProject = $.ajax({type: 'POST',url: 'https://www.pharmaceutical-business-review.com/wp-admin/admin-ajax.php?action=mega_posts',data: data_obj, dataType: "html",beforeSend: function() {$('.megamenuthird[data-menu=' + ajaxreplaceContent+ ']').html('');},success: function(response) {$('.megamenuthird[data-menu=' + ajaxreplaceContent + ']').html(response);},error: function(xhr) { // if error occured$('.megamenuthird[data-menu=' + ajaxreplaceContent + ']').html("Error occured.please try again");}});}//Subchild Level Menu Hover//Child Level Menu Hoverfunction get_subchildlevelmenu(currentid){var $currentelement = $('#'+currentid);$('.menu-item-'+$('#'+currentid).closest('.themegamenu').attr('cid').split('-')[3]).removeClass('defaultajax-1');var $data_menu = $currentelement.closest('li').attr('data-menu'); var submenu = $data_menu.split('-'); var data_menu_class=submenu[0];var ajaxreplaceContent = $('#'+currentid).closest('.themegamenu').data('megamenu')+'-articles';$('.megamenuthird[data-menu=' + ajaxreplaceContent + ']').empty();$('.megamenuthird').removeClass('megamenuthird-show');$('.megamenuthird[data-menu=' + $data_menu + ']').addClass('megamenuthird-show');$('li.level_3').removeClass('activeli');$currentelement.closest('li').addClass('activeli');var subChildLevel_title = $currentelement.html();//last child level$currentelement.closest('li').parent().closest('li').find('.megamenusecond-new[data-menu=' + $data_menu + ']').find('li.level_4').removeClass('activeli');var $data_menu = $('#'+currentid).closest('li').data('menu');$('.megamenuopen .megamenusecond-new').removeClass('megamenusecond-show');$currentelement.closest('li').parent().closest('li').find('.megamenusecond-new[data-menu=' + $data_menu + ']').addClass('megamenusecond-show');$currentelement.closest('li').parent().closest('li').find('.megamenusecond-new[data-menu=' + $data_menu + ']').find('li.level_4:first-child').addClass('activeli');//console.log('subchild-'+title);var subChildLevel_cat_id=$currentelement.closest('li').data("cat");var subChildLevel_taxnomy_type = $currentelement.closest('li').data("type");var ChildLevel_data_type= $(".mega-options > li.project_m.activeli").data("type");var ChildLevel_data_cat_id= $(".mega-options > li.project_m.activeli").data("cat_id");var parent_data_cat_id= $currentelement.closest('.themegamenu').data("main_cat_id");var parent_data_type= $currentelement.closest('.themegamenu').data("main_type");// checking 4th level menu /*** 4th level Objec code here **/// End getting parent data-menuif($('.megamenusecond.megamenusecond-new').length > 0){var subofSubChildLevel_cat_id = $('.megamenusecond[data-menu='+$data_menu+']').find('li.level_4.activeli').data('cat');var subofSubChildLevel_data_menu = $('.megamenusecond[data-menu='+$data_menu+']').find('li.level_4.activeli').data('menu');var subofSubChildLevel_taxnomy_type= $('.megamenusecond[data-menu='+$data_menu+']').find('li.level_4.activeli').data('type');var subofSubChildLevel_title = $('.megamenusecond[data-menu='+$data_menu+']').find('li.level_4.activeli>a').html();if(subofSubChildLevel_title!==''){var ajx_title=subofSubChildLevel_title;}else{var ajx_title=subChildLevel_title;}if(subofSubChildLevel_cat_id!=''){var data_obj= {'title':ajx_title,'subofSubChildLevel_cat_id':subofSubChildLevel_cat_id,'subofSubChildLevel_taxnomy_type':subofSubChildLevel_taxnomy_type,'subChildLevel_cat_id': subChildLevel_cat_id,'subChildLevel_taxnomy_type' :subChildLevel_taxnomy_type,'ChildLevel_data_type':ChildLevel_data_type,'ChildLevel_data_cat_id':ChildLevel_data_cat_id,'parent_data_cat_id':parent_data_cat_id,'parent_data_type':parent_data_type};}else{var data_obj= {'title':ajx_title,'subChildLevel_cat_id': subChildLevel_cat_id,'subChildLevel_taxnomy_type' :subChildLevel_taxnomy_type,'ChildLevel_data_type':ChildLevel_data_type,'ChildLevel_data_cat_id':ChildLevel_data_cat_id,'parent_data_cat_id':parent_data_cat_id,'parent_data_type':parent_data_type};}}else{var data_obj= {'title':subChildLevel_title,'subChildLevel_cat_id': subChildLevel_cat_id,'subChildLevel_taxnomy_type' :subChildLevel_taxnomy_type,'ChildLevel_data_type':ChildLevel_data_type,'ChildLevel_data_cat_id':ChildLevel_data_cat_id,'parent_data_cat_id':parent_data_cat_id,'parent_data_type':parent_data_type};} if( ajaxRequestProject != null ) {ajaxRequestProject.abort();ajaxRequestProject = null;}ajaxRequestProject = $.ajax({ type: 'POST', url: 'https://www.pharmaceutical-business-review.com/wp-admin/admin-ajax.php?action=mega_posts', dataType: "html", data: data_obj, beforeSend: function() {$('.megamenuthird[data-menu=' + ajaxreplaceContent + ']').html('');},success: function(response) {$('.megamenuthird[data-menu=' + ajaxreplaceContent + ']').html(response);},error: function(xhr) { // if error occured$('.megamenuthird[data-menu=' + ajaxreplaceContent + ']').html("Error occured.please try again"); }});}//last child levelfunction get_lastchildlevelmenu(currentid){var $currentelement = $('#'+currentid);$('.menu-item-'+$('#'+currentid).closest('.themegamenu').attr('cid').split('-')[3]).removeClass('defaultajax-1');var $data_menu = $currentelement.closest('li').attr('data-menu'); var submenu = $data_menu.split('-'); var data_menu_class=submenu[0];var $ajax_data_menu = $currentelement.closest('li').attr('data-ajax'); var ajax_submenu = $ajax_data_menu.split('-'); var ajax_data_menu_class=ajax_submenu[0]+'-'+ajax_submenu[1];var ajaxreplaceContent = $('#'+currentid).closest('.themegamenu').data('megamenu')+'-articles';$('.megamenuthird[data-menu=' + ajaxreplaceContent + ']').empty();$('.megamenuthird').removeClass('megamenuthird-show');$('.megamenuthird[data-menu=' + $data_menu + ']').addClass('megamenuthird-show');$('li.level_4').removeClass('activeli');$currentelement.closest('li').addClass('activeli');var title = $currentelement.html();var subofSubChildLevel_cat_id=$currentelement.closest('li').data("cat");var subofSubChildLevel_taxnomy_type = $currentelement.closest('li').data("type");var subofSubChildLevel_title = $currentelement.closest('li').find('li.level_4.activeli>a').html();var subChildLevel_cat_id=$('.megamenusecond[data-menu='+ajax_data_menu_class+']').find('li.level_3.activeli').data('cat');var subChildLevel_data_menu=$('.megamenusecond[data-menu='+ajax_data_menu_class+']').find('li.level_3.activeli').data('menu');var subChildLevel_taxnomy_type = $('.megamenusecond[data-menu='+ajax_data_menu_class+']').find('li.level_3.activeli').data('type');var ChildLevel_data_type= $(".mega-options > li.project_m.activeli").data("type");var ChildLevel_data_cat_id= $(".mega-options > li.project_m.activeli").data("cat_id");var parent_data_cat_id= $currentelement.closest('.themegamenu').data("main_cat_id");var parent_data_type= $currentelement.closest('.themegamenu').data("main_type");var data_obj= {'title':title,'subofSubChildLevel_cat_id':subofSubChildLevel_cat_id,'subofSubChildLevel_taxnomy_type':subofSubChildLevel_taxnomy_type,'subChildLevel_cat_id': subChildLevel_cat_id,'subChildLevel_taxnomy_type' :subChildLevel_taxnomy_type,'ChildLevel_data_type':ChildLevel_data_type,'ChildLevel_data_cat_id':ChildLevel_data_cat_id,'parent_data_cat_id':parent_data_cat_id,'parent_data_type':parent_data_type};if( ajaxRequestProject != null ) {ajaxRequestProject.abort();ajaxRequestProject = null;}ajaxRequestProject = $.ajax({ type: 'POST', url: 'https://www.pharmaceutical-business-review.com/wp-admin/admin-ajax.php?action=mega_posts', dataType: "html", data:data_obj, beforeSend: function() {$('.megamenuthird[data-menu=' + ajaxreplaceContent + ']').html('');},success: function(response) {$('.megamenuthird[data-menu=' + ajaxreplaceContent + ']').html(response);},error: function(xhr) { // if error occured$('.megamenuthird[data-menu=' + ajaxreplaceContent + ']').html("Error occured.please try again"); }});} $(document).ready(function(){//$('body').addClass('loaded');/********* End Third Level on over show/hide ****/$('.news-box-big').hover(function() {$(this).closest('.news').children('.big_title').toggleClass("bordertop");});$('.news-box-medium').hover(function() {$(this).closest('.medium_title').children('.tbt').toggleClass("bordertop");}); /********* Newsletter onclick events start here *******/ $(".header-cta a").click(function(e){ var $elem = $('.newsletter-box').position(); $('html,body').animate({ scrollTop: $(".newsletter-box").offset().top - 80}, 'fast'); }); /***** Newsletter onclick events End here *******/ /* Close guided tour */ $(".close-guided-tour").click(function(){$(".home_timeline").hide(); }); /* Close guided tour */ $(".close-guided-tour2").click(function(){ $(".timeline-tour2").hide(); }); /* $( ".fa-search" ).click(function() { $( 'body' ).toggleClass('search-open'); //$('.search-form').toggle(); }); $('.search-toggle').click(function () {$('.search-form').toggleClass('expanded');}); */ // Search toggle$('.navbar .search-toggle, .mobilesearch').click(function(e){e.preventDefault();$(this).parent().toggleClass('active').find('input[type="search"]').focus();});$('.search-submit').click(function(e){if( $(this).parent().find('.search-field').val() == '' ) {e.preventDefault();$(this).parent().parent().removeClass('active');}}); }); /* Reached newsletter */ $(function(){ $(document).scroll(function(){ if($(this).scrollTop() >= $('.email-capture').offset().top - 50) { $('body').addClass("email-capture-reached"); } else{ $('body').removeClass("email-capture-reached"); } if($(this).scrollTop() >= $('.timeline').offset().top - 50) { $('body').addClass("timeline-tour-open"); } else{ $('body').removeClass("timeline-tour-open"); } }); }); /****** Article page Share n/w ********/ $('.social-toggle').on('click', function() { $(this).next().toggleClass('open-menu'); }); /*** End Article page Share n/w ********/ /* Close guided tour */ $(".close-guided-tour2").click(function(){ $("body").addClass("timeline-closed"); }); /* End Timeline guided tour Track the news */ /* Reached related headline */ $(function(){ $(document).ready(function(){ $('body').addClass("headline-reached"); }); }); /* Reached start */ /*$(function(){ $(document).scroll(function(){ if($(this).scrollTop() >= $('#start').offset().top - 50) { $('body').addClass("start-reached"); } else{ $('body').removeClass("start-reached"); } }); });*/ /* Reached share-content */ $(function(){ $(document).scroll(function(){ if($(this).scrollTop() >= $('.share-content').offset().top - 50) { $('body').addClass("share-content-reached"); } else{ $('body').removeClass("share-content-reached"); } }); }); /* share copy-link section */ function myFunction() { var copyText = document.getElementById("copylink"); copyText.select(); document.execCommand("Copy"); } /* Reached first sidebar mpu */ $(function(){ $(document).scroll(function(){ if($(this).scrollTop() >= $('.mpu1').offset().top - 50) { $('body').addClass("reached-mpu1"); } else{ $('body').removeClass("reached-mpu1"); } }); }); /* Sticky sidebar banner */ /* $(function(){ $(document).scroll(function(){ if ($(window).width() > 1400) { if($(this).scrollTop() >= $('#sticky-mpu').offset().top - 250 ) { $('.sidebar').addClass("banner-fixed"); } else{ $('.sidebar').removeClass("banner-fixed"); } } }); });*/ // Select all links with hashes $('a[href*="#"]') // Remove links that don't actually link to anything .not('[href="#"]') .not('[href="#0"]') .click(function(event) { // On-page links if ( location.pathname.replace(/^//, '') == this.pathname.replace(/^//, '') && location.hostname == this.hostname ) { // Figure out element to scroll to var target = $(this.hash); target = target.length ? target : $('[name=' + this.hash.slice(1) + ']'); // Does a scroll target exist? if (target.length) { // Only prevent default if animation is actually gonna happen event.preventDefault(); $('html, body').animate({ scrollTop: target.offset().top }, 1000, function() { // Callback after animation // Must change focus! var $target = $(target); $target.focus(); if ($target.is(":focus")) { // Checking if the target was focused return false; } else { $target.attr('tabindex','-1'); // Adding tabindex for elements not focusable $target.focus(); // Set focus again }; }); } } }); /******** onclick share button in catgeory page ******/ $(".share-button").click(function(){ if($(this).parent('.open-share').length == 0){ $('.share').removeClass('open-share'); $(this).parent('.share').addClass("open-share"); }else{ $('.share').removeClass('open-share'); } }); /************* Mobile menu js *******/ function openNav() { document.getElementById("mobilemenu").style.width = "100%"; document.getElementById("mobilemenu").style.left = "0px"; } function closeNav() { document.getElementById("mobilemenu").style.width = "0"; } $( ".mobilemenuicon" ).click(function() { setTimeout(function(){ $( '.mobile-menu-cta' ).addClass("mobilectashow"); }, 500); }); $( ".closebtn" ).click(function() { $( '.mobile-menu-cta' ).removeClass("mobilectashow") }); /********** End mobile menu js *******/ /********* contractors Single page close Header**/ $(".close_section").click(function(){ $('.headersf').hide(1000); $('.headersf').addClass('section_closed'); $('.header-singleproduct').addClass('margin_top_added'); $('.small_header_sf').addClass('small_header_sf_display'); }); /******* End contractors Single page close Header**/ /*** My accout drop down menu */ $('.ctanav .dropdown-menu a').on('click', function() { window.location.href = $(this).attr('href'); }); /*** cookie-popup **/ $("#cookiepopup-continue").click(function(){ $.cookie("cookie_compelo", 'https://www.pharmaceutical-business-review.com'); $('.home_timeline').hide(); }); $(window).on("load",function(){ var data = $.cookie("cookie_compelo"); if(data){ $('.home_timeline').hide(); }else{ $('.home_timeline').show(); } }); $(".home_timeline .close").click(function(){ $.cookie("cookie_compelo", 'https://www.pharmaceutical-business-review.com'); $('.home_timeline').hide(); }); $(window).on("load",function(){ var data = $.cookie("cookie_compelo"); if(data){ $('.home_timeline').hide(); }else{ $('.home_timeline').show(); } }); /*** End cookie popup **/ /**** New add js code ***/ if ($(window).width() > 960) { // Initialization $(function(){ $('[data-scroll-speed]').moveIt(); }); } /* Sticky sidebar banner EVENT PAGE */ $(function(){ $(document).scroll(function(){ var scroll = $(window).scrollTop(); if (scroll >= 655) { $('.sticky-mpu-event').addClass("banner-fixed"); } else{ $('.sticky-mpu-event').removeClass("banner-fixed"); } }); }); //advertising page jQuery.fn.moveIt = function(){ var $window = jQuery(window); var instances = []; jQuery(this).each(function(){ instances.push(new moveItItem($(this))); }); window.addEventListener('scroll', function(){ var scrollTop = $window.scrollTop(); instances.forEach(function(inst){ inst.update(scrollTop); }); }, {passive: true}); } var moveItItem = function(el){ this.el = jQuery(el); this.speed = parseInt(this.el.attr('data-scroll-speed')); }; moveItItem.prototype.update = function(scrollTop){ this.el.css('transform', 'translateY(' + -(scrollTop / this.speed) + 'px)');};// InitializationjQuery(function(){jQuery('[data-scroll-speed]').moveIt();}); /**** end new add js code **/

Read this article:
GSK, Vir Biotechnology to expand Covid-19 treatment study - Pharmaceutical Business Review

The 67 rating InvestorsObserver gives to Enlivex Therapeutics Ltd (ENLV) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 85 percent of stocks in the Biotechnology industry, ENLVs 67 overall rating means the stock scores better than 67 percent of all stocks.

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 67 would rank higher than 67 percent of all stocks.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

Enlivex Therapeutics Ltd (ENLV) stock has gained 3.47% while the S&P 500 has fallen -1.28% as of 11:11 AM on Friday, Oct 2. ENLV is up $0.31 from the previous closing price of $8.79 on volume of 2,317,076 shares. Over the past year the S&P 500 has gained 14.67% while ENLV has fallen -18.60%. ENLV lost -$0.83 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Enlivex Therapeutics Ltd (ENLV) Stock.

Continue reading here:
Where Does Enlivex Therapeutics Ltd (ENLV) Stock Fall in the Biotechnology Field? - InvestorsObserver

Fort Collins, Colorado The Biotechnology Market is growing at a rapid pace and contributes significantly to the global economy in terms of turnover, growth rate, sales, market share and size. The Biotechnology Market Report is a comprehensive research paper that provides readers with valuable information to understand the basics of the Biotechnology Report. The report describes business strategies, market needs, dominant market players and a futuristic view of the market.

The report has been updated to reflect the most recent economic scenario and market size regarding the ongoing COVID-19 pandemic. The report looks at the growth outlook as well as current and futuristic earnings expectations in a post-COVID scenario. The report also covers changing market trends and dynamics as a result of the pandemic and provides an accurate analysis of the impact of the crisis on the market as a whole.

Biotechnology market garnered a revenue of USD 398.42 billion in the year 2019 globally and has been foreseen to yield USD 622.27 billion by the year 2027 at a compound annual growth (CAGR) of 7.2% over the forecast period.

Get a sample of the report @ https://reportsglobe.com/download-sample/?rid=80612

Industry Biotechnology Study provides an in-depth analysis of key market drivers, opportunities, challenges and their impact on market performance. The report also highlights technological advancements and product developments that drive market needs.

The report contains a detailed analysis of the major players in the market, as well as their business overview, expansion plans and strategies. Key players explored in the report include:

The report provides comprehensive analysis in an organized manner in the form of tables, graphs, charts, pictures and diagrams. Organized data paves the way for research and exploration of current and future market outlooks.

Request a Discount on the report @ https://reportsglobe.com/ask-for-discount/?rid=80612

The report provides comprehensive data on the Biotechnology market and its trends to help the reader formulate solutions to accelerate business growth. The report provides a comprehensive overview of the economic scenario of the market, as well as its benefits and limitations.

The Biotechnology Market Report includes production chain analysis and value chain analysis to provide a comprehensive picture of the Biotechnology market. The research consists of market analysis and detailed analysis of application segments, product types, market size, growth rates, and current and emerging industry trends.

Biotechnology Market, By Application (2016-2027)

Biotechnology Market, By Technology (2016-2027)

Request customization of the report @https://reportsglobe.com/need-customization/?rid=80612

The market is geographically spread across several key geographic regions and the report includes regional analysis as well as production, consumption, revenue and market share in these regions for the 2020-2027 forecast period. Regions include North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

Radical Coverage of the Biotechnology Market:

Key Questions Addressed in the Report:

To learn more about the report, visit @ https://reportsglobe.com/product/biotechnology-market-2/

Thanks for reading our report. It is possible to adapt this report to the wishes of the customer. Contact us to learn more about the report and our team will make sure you create a report based on your needs.

How Reports Globe is different than other Market Research Providers

The inception of Reports Globe has been backed by providing clients with a holistic view of market conditions and future possibilities/opportunities to reap maximum profits out of their businesses and assist in decision making. Our team of in-house analysts and consultants works tirelessly to understand your needs and suggest the best possible solutions to fulfill your research requirements.

Our team at Reports Globe follows a rigorous process of data validation, which allows us to publish reports from publishers with minimum or no deviations. Reports Globe collects, segregates, and publishes more than 500 reports annually that cater to products and services across numerous domains.

Contact us:

Mr. Mark Willams

Account Manager

US: +1-970-672-0390

Email:[emailprotected]

Web:reportsglobe.com

Excerpt from:
Biotechnology Market Potential Growth, Size, Share, Demand and Analysis of Key Players Research Forecasts to 2027 - The Daily Chronicle

A rating of 3 puts Aptorum Group Ltd (APM) near the bottom of the Biotechnology industry according to InvestorsObserver. Aptorum Group Ltd's score of 3 means it scores higher than 3% of stocks in the industry. Aptorum Group Ltd also received an overall rating of 8, putting it above 8% of all stocks. Biotechnology is ranked 25 out of the 148 industries.

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.

Aptorum Group Ltd (APM) stock is trading at $2.79 as of 1:12 PM on Wednesday, Oct 7, an increase of $0.10, or 3.72% from the previous closing price of $2.69. The stock has traded between $2.70 and $2.99 so far today. Volume today is 2,313,374 compared to average volume of 2,976,804.

Click Here to get the full Stock Score Report on Aptorum Group Ltd (APM) Stock.

Visit link:
Is Aptorum Group Ltd (APM) Stock Near the Top of the Biotechnology Industry? - InvestorsObserver

Sept. 25, 2020 11:00 UTC

LEXINGTON, Mass.--(BUSINESS WIRE)-- Accent Therapeutics, a biopharmaceutical company developing breakthrough treatments for cancer patients, announced today the appointment of Julie Hambleton, M.D., to its board of directors. Dr. Hambleton brings extensive clinical oncology drug development and regulatory expertise gained in leadership roles within both the biotechnology and pharmaceutical industries.

We are delighted to welcome Julie to the Accent Board of Directors, said Shakti Narayan, Ph.D., J.D., Chief Executive Officer of Accent. Her insight and experience will be invaluable as we continue to advance our pipeline of novel therapies targeting RNA-modifying proteins.

Accent is developing an exciting pipeline of targeted therapies in this novel area of biology, said Dr. Hambleton. Im thrilled to be working with the board of directors and the Accent team to deliver life-changing therapies to patients.

Dr. Hambleton is a senior biotechnology executive with more than 20 years of experience in clinical drug development from pre-clinical through Phase 4 and post-marketing studies. She has extensive experience working with regulatory agencies, including the U.S. FDA and the European Medicines Agency (EMA), and in filings of Investigational New Drug Applications (INDs), Biologics License Applications (BLAs) and Special Protocol Assessments (SPAs). Dr. Hambleton currently serves as interim Chief Executive Officer at Arch Oncology. Previously, she served as Senior Vice President, Chief Medical Officer and Head of Development at IDEAYA Biosciences, an oncology medicine company, until April 2020. Prior to her role at IDEAYA, she held the positions of Vice President, Head of U.S. Medical at Bristol-Myers Squibb, where she oversaw Medical & Health Economic and Outcomes Research activities in support of the Oncology, Immuno-Oncology, Specialty and Cardiovascular marketed portfolios; Executive Vice President and Chief Medical Officer at Five Prime Therapeutics; and Vice President, Clinical Development, at Clovis Oncology.

Dr. Hambleton began her industry career at Genentech, most recently as Group Medical Director, Global Clinical Development, leading a cross-functional group conducting Phase 2 and 3 trials of Avastin. She also serves on the boards of directors of IGM Biosciences, Inc. and SpringWorks Therapeutics, Inc., both publicly traded biotechnology companies, as well as Arch Oncology, a privately-held biotechnology company. Dr. Hambleton completed her medical and hematology-oncology training at the University of California, San Francisco, where she then served on faculty from 1993 to 2003. She received a B.S. from Duke University, and her M.D. from Case Western Reserve University School of Medicine and was Board-certified in Hematology and Internal Medicine.

About Accent Therapeutics

Accent Therapeutics is a biopharmaceutical company developing oncology-focused, small molecule therapies in the emerging field of RNA modification. This field of biology encompasses post-transcriptional chemical modifications of RNA that provide cells with a unique mechanism for regulating proteins critical for cellular growth and differentiation. By targeting cancer-linked RNA-modifying proteins (RMPs) with precision therapies, the Company aims to translate extraordinary science into life-changing therapies for patients. For more information, please visit http://www.accenttx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200925005036/en/

See the rest here:
Accent Therapeutics Appoints Oncology Drug Development Veteran Julie Hambleton to its Board of Directors - BioSpace

A rating of 79 puts Intellia Therapeutics Inc (NTLA) near the top of the Biotechnology industry according to InvestorsObserver. Intellia Therapeutics Inc's score of 79 means it scores higher than 79% of stocks in the industry. Intellia Therapeutics Inc also received an overall rating of 64, putting it above 64% of all stocks. Biotechnology is ranked 26 out of the 148 industries.

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as good for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 64 means the stock is more attractive than 64 percent of stocks.

These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

Intellia Therapeutics Inc (NTLA) stock is trading at $83.77 as of 10:40 AM on Friday, Jan 8, a rise of $6.29, or 8.12% from the previous closing price of $77.48. The stock has traded between $75.64 and $86.13 so far today. Volume today is light. So far 972,367 shares have traded compared to average volume of 1,765,098 shares.

Click Here to get the full Stock Score Report on Intellia Therapeutics Inc (NTLA) Stock.

Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.

You May Also Like

Follow this link:
Is Intellia Therapeutics Inc (NTLA) a Winner in the Biotechnology Industry? - InvestorsObserver

Vaxart Inc (VXRT) is around the top of the Biotechnology industry according to InvestorsObserver. VXRT received an overall rating of 81, which means that it scores higher than 81 percent of all stocks. Vaxart Inc also achieved a score of 93 in the Biotechnology industry, putting it above 93 percent of Biotechnology stocks. Biotechnology is ranked 23 out of the 148 industries.

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 81 would rank higher than 81 percent of all stocks.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

Vaxart Inc (VXRT) stock has risen 8.5% while the S&P 500 is lower by -1.67% as of 11:41 AM on Monday, Sep 21. VXRT is up $0.70 from the previous closing price of $8.22 on volume of 23,715,904 shares. Over the past year the S&P 500 has gained 9.10% while VXRT is up 1615.38%. VXRT lost -$0.60 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Vaxart Inc (VXRT) Stock.

See the rest here:
Is Vaxart Inc (VXRT) The Right Choice in Biotechnology? - InvestorsObserver

FibroGen Inc (FGEN) is near the top in its industry group according to InvestorsObserver. FGEN gets an overall rating of 55. That means it scores higher than 55 percent of stocks. FibroGen Inc gets a 67 rank in the Biotechnology industry. Biotechnology is number 30 out of 148 industries.

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

FibroGen Inc (FGEN) stock is trading at $43.16 as of 11:50 AM on Thursday, Dec 17, a rise of $1.20, or 2.86% from the previous closing price of $41.96. The stock has traded between $41.87 and $43.69 so far today. Volume today is low. So far 205,869 shares have traded compared to average volume of 662,163 shares.

Click Here to get the full Stock Score Report on FibroGen Inc (FGEN) Stock.

Read more:
Is FibroGen Inc (FGEN) The Right Choice in Biotechnology? - InvestorsObserver

Queensland, Australia, Dec. 23, 2020 (GLOBE NEWSWIRE) -- Rayont Inc. (Rayont or the Company) (OTC PINK: RAYT), an expanding company focused on biotechnology, education and technology industries globally, today completed the acquisition of naturopathic and homeopathic manufacturer and distributor, Prema Life Pty Ltd (Prema Life). The Company also acquired 100% ownership of GGLG Properties Pty Ltd (GGLG) as trustee for (ATF) Gillard Property Trust, the property where Prema Life operates. Whilst this is a related party transaction, all relevant documents are being executed on an arms length basis and in keeping with all necessary legal and regulatory requirements.

Under the agreement Rayont Inc, through its wholly owned subsidiary Rayont (Australia) Pty Ltd, acquires 100% of the total outstanding shares and units of Prema Life, and GGLG in exchange for AU$1.5M (approximately US$1.1M) cash payable overseven installments within 180 days to Thealikasa (Australia) Pty Ltd who is the sole shareholder of record of Prema Life and GGLG, a major shareholder in Rayont Inc. The price is a 10% discount of the combined Net Tangible Asset value of both Companies.

In the event that Rayont Inc is unable to pay in cash, Thealikasa (Australia) Pty Ltd will accept shares based on a 20% discount of the average share price for the last 30 trading days from the December 22, 2020, that is USD 0.87 per share.

To comply with Australian foreign investment rules and regulations, Rayont (Australia) Pty Ltd is required to obtain written consent from the Australian Foreign Investment Review Board before the transfer of shares and units of GGLG Properties Pty Ltd (ATF) Gillard Property Trust.

Marshini Thulkanam, President and CEO of Rayont Inc stated, the acquisition of Prema Life and GGLG, in addition to our earlier investments in Next Generation Photo Dynamic Therapy (NGPDT) to treat cancer, enables Rayont to become one of the premiere one-stop nutraceutical biotechnology companies with research & development, manufacturing, distribution, education and support capabilities in Australia and the South East Asian region. With more than 20 years of trading history, Prema Life is positioned to increase revenue and profitability moving forward.

About Prema Life Pty Ltd

Prema Life is a HACCP certified manufacturer and supplier of functional foods and supplements, and of practitioner only naturopathic and homeopathic medicines. The Company produces an extensive range of products including proteins, green blends, sports nutrition, weight management and maintenance, and health and wellness products. Prema Life is well positioned through expanded contract manufacturing arrangements, direct to practitioner sales, over the counter sales via distributors, and through increased online sales of proprietary branded products.

The company hosts regular educational webinars and seminars for its extensive practitioners' network to learn about the products, which in turn facilitates sales to their customers.

Prema Life has been in alternative health products manufacturing, distribution and support for more than 20 years and has a total workforce of 22 people as of the day of the acquisition. Its revenues for the financial year ending June 30, 2020 were US$1,769,746, and a net loss of US$46,917 (based on todays exchange rate).

For more information: http://nva.com.au https://premalifeaustralia.comhttps://wonderfoods.com.au

About GGLG Properties Pty Ltd

GGLG is the owner and operator of 11 Aldinga Street, Brendale, Queensland, 4500, Australia. The facility has an area of 21,000 square feet with single floor buildings and is leased to Prema Life. The immediate plan is to build a double story building of 37,673 square feet for office, production and logistical support of Prema Life. The design and planning for this are in process at present.

The expanded facility will enable Prema Life to significantly increase production capacity and expand the scope of its product range and service offering in line with future growth strategies.

About Rayont Inc.

Rayont Inc. is a Nevada based company incorporated since 2011. As an expanding company, Rayont focuses on biotechnology, education and technology industries globally. The Company has made significant investments in the biotechnology and life sciences sectors by acquiring assets to operate cancer treatment technologies. In addition to having plans to grow its biotechnology portfolio by identifying, acquiring and integrating other assets within the healthcare area, the Company has investments in technology and education assets that offer remote education, artificial intelligence (AI), augmented reality (AR), remote learning solutions, end-to-end employee engagement platforms, and cloud-based platform technologies.

For further information, please visitwww.rayont.com

SAFE HARBOR

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, are subject to Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbors created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.

Read more:
RAYONT INC. - RAYT, Acquires Prema Life Pty Ltd and GGLG Properties Pty Ltd to Consolidate its Biotechnology and Health Care Portfolio. -...

LONDON--(BUSINESS WIRE)--The new cleanroom consumables market research report from Technavio indicates positive growth in the short term as the business impact of COVID-19 spreads.

Get detailed insights on the COVID-19 pandemic Crisis and Recovery analysis of the cleanroom consumables market. Download free report sample

"One of the primary growth drivers for this market is the growth of pharmaceutical and biotechnology industries in APAC, says a senior analyst for Industrials at Technavio.

The pharmaceutical and biotechnology industries are witnessing high growth in APAC, especially in developing countries such as China and India. This can be attributed to various initiatives taken by regulatory bodies to strengthen the pharmaceutical industry. For instance, the Government of India allocated about USD 8.8 billion in its Union Budget 2019-2020 for the development of the healthcare sector. The country has also eased the FDI rules to attract investments in the healthcare sector. Many such factors have been contributing to the growth of the pharmaceutical and biotechnology industries in APAC. The pharmaceutical and biotechnology industries are the major end-users of cleanroom consumables. Thus, all these factors are expected to drive the demand for cleanroom consumables during the forecast period. As the markets recover Technavio expects the cleanroom consumables market size to grow by USD 2.64 billion during the period 2020-2024.

Cleanroom Consumables Market Segment Highlights for 2020

Regional Analysis

Click here to learn about report detailed analysis and insights on how you can leverage them to grow your business.

Notes:

Register for a free trial today to access 17,000+ market research reports using Technavio's SUBSCRIPTION platform

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Read the original:
Cleanroom Consumables Market Report by Technavio Identifies the Growth of Pharmaceutical and Biotechnology Industries in APAC as Key Driver |...

The 5 rating InvestorsObserver gives to Tauriga Sciences Inc (TAUG) stock puts it near the bottom of the Biotechnology industry. In addition to scoring higher than 4 percent of stocks in the Biotechnology industry, TAUGs 5 overall rating means the stock scores better than 5 percent of all stocks.

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 5 would rank higher than 5 percent of all stocks.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

Tauriga Sciences Inc (TAUG) stock is unmoved -5% while the S&P 500 is down -0.21% as of 11:20 AM on Wednesday, Dec 2. TAUG is unmoved $0.00 from the previous closing price of $0.03 on volume of 482,338 shares. Over the past year the S&P 500 is higher by 18.16% while TAUG is unmoved 0.00%. TAUG lost -$0.04 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Tauriga Sciences Inc (TAUG) Stock.

Excerpt from:
Where Does Tauriga Sciences Inc (TAUG) Stock Fall in the Biotechnology Field? - InvestorsObserver

Global Neurofibromatoses Type II Therapecutics Market 2020 by Manufacturers, Type and Application, Forecast to 2025 comes as one of the hard-to-find market data reports published by MarketsandResearch.biz that determine the market growth and market share for the estimated forecast period. The report examines trends, industry development, industry structure, supply and demand, industry capacity, marketing channels, and leading industry participants. The report shows several business perspectives on important factors such as key geographies, major key players, opportunities, drivers, restraints, and challenges. Historical data and long-term forecasts through 2020 and 2025 are an important part of this global Neurofibromatoses Type II Therapecutics market research document. The study contains an examination of dynamic aspects such as industrial structure, application, classification, and definition.

What It Consist of?

The report involves classified segmentation of market covering product type, application, players, and regions. The research determines the competitive landscape of the market share, market size, for the estimated forecast period. The report covers the recent and futuristic Neurofibromatoses Type II Therapecutics market share of each region alongside the significant nations in the respective regions. The research consists of info graphics and diagrams that show easy to understand examination of the global market. It provides an insight into the aspects within this segment that may encourage or demote the expansion of the global industry.

NOTE: Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketsandresearch.biz/sample-request/66902

Key players profiled in the report include: Arno Therapeutics Inc, Lixte Biotechnology Holdings Inc, AstraZeneca Plc, Beta Pharma Inc, Recursion Pharmaceuticals Inc, Plex Pharmaceuticals Inc

Next, the report uncovers the gaps and opportunities to derive the most relevant insights from our research document to gain global Neurofibromatoses Type II Therapecutics market size. For the region, type, and application, the sales, revenue, and market share, growth rate are key research objects. Here the report considers the key aspects such as areas of operation, production, and product portfolio as well as company size, market share, market growth, production volume, and profits.

Market segment by type, the product can be split into: AR-42, FRAX-597, Icotinib Hydrochloride, LB-201, LB-205, Others

Market segment by regions/countries, this report covers: Clinic, Hospital, Home Care

The report offers examination and growth of the market in these districts covering: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia and Italy), Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia), South America (Brazil, Argentina), Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)

The next section of the report takes a close review of the challenges and threats prevalent in the global Neurofibromatoses Type II Therapecutics market. The report also includes classified information and intelligence related to geographical expanse, regional overview, as well as vital details associated with country-specific developments that have also been addressed in the report.

ACCESS FULL REPORT: https://www.marketsandresearch.biz/report/66902/global-neurofibromatoses-type-ii-therapecutics-market-2020-by-manufacturers-type-and-application-forecast-to-2025

Crucial Highlights of The Market Report:

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team (sales@marketsandresearch.biz), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: sales@marketsandresearch.bizWeb: http://www.marketsandresearch.biz

See more here:
Global Neurofibromatoses Type II Therapecutics Market With COVID-19 Revenue 2020 | Arno Therapeutics Inc, Lixte Biotechnology Holdings Inc - The...

Global Agriculture Biotechnology Market Research Report offers a in-depth view on market trends, forecast statistics, company profile, growth drivers and latest industry insights. The report covers all the Agriculture Biotechnology type, applications, deployment models, research regions. A deep-dive analysis on leading Agriculture Biotechnology industry players, their market share, production volume, gross margin analysis from 2015-2019 is provided. Challenges to the Agriculture Biotechnology development, growth opportunities, market drivers, restraints are described in this report.

The market value, market share, production and gross margin of Agriculture Biotechnology is covered for every type, application, and geographical regions. Also, import-export scenario, regional SWOT analysis, and market status is elaborated. Agriculture Biotechnology Forecast covers type, application and regional forecast for market value, volume, and consumption from 2020 to 2026. Industry barriers, investment feasibility, and opportunities to the new Agriculture Biotechnology market players are analyzed in this report.

Global Agriculture Biotechnology market is subdivided based on type, application and research regions. Top regions studied in this report include North America, Europe, Asia-Pacific, South America, Middle East & Africa. For each region, production value and growth rate is covered from 2015 to 2019. The information on market concentration and market maturity analysis will lead to investment feasibility.

Get Free Sample(COVID-19 Impact Analysis Updated Sample):@:

https://www.reportspedia.com/report/life-sciences/global-agriculture-biotechnology-market-research-report-2020-2026-of-major-types,-applications-and-competitive-vendors-in-top-regions-and-countries/54704#request_sample

Major players covered in this report:

ADAMA Agricultural SolutionsVilmorinBayerBiocentury TransgeneCertisDow AgroSciencesEurofinsEvogeneGlobal Bio-chem TechnologySyngentaKWS SaatMarina BiotechMonsanto

Global Agriculture Biotechnology Market Segmentation:

By Type:

BiochipsDeoxy ribonucleic acid (DNS) sequencingGenome editing toolsRibonucleic acid interference (RNAI)Synthetic biology

By Application:

Transgenic crops marketSynthetic biology-enabled products market

Market drivers explain the emerging countries and Agriculture Biotechnology growth. Also, the limitations, opportunities, latest industry plans, and policies are offered. Industry chain analysis explains upstream raw material suppliers, key market players, production process analysis, Agriculture Biotechnology manufacturing cost structures, and global market share of Agriculture Biotechnology in 2019. This in-depth study explains the cost of raw materials, labor cost, marketing channels and major downstream buyers of Agriculture Biotechnology .

Get Up to 30% Off on purchasing this report, Ask Here for Discount @:

https://www.reportspedia.com/discount_inquiry/discount/54704

This study analyzes the Agriculture Biotechnology industry market status and forecast statistics explaining the production, revenue, consumption ratio, and historic market trends. All the manufacturers, market share, company profiles, production capacity, and gross margin analysis of Agriculture Biotechnology is presented in this report. The industry breakdown based on product type, applications, regions, and manufacturer will provide sophisticated Agriculture Biotechnology market view. Recent Agriculture Biotechnology developments, opportunities, challenges, and business strategies are explained. The influencing factors, product launches, mergers and acquisition of Agriculture Biotechnology is covered in this study.

The report also explains the demand and supply side of Agriculture Biotechnology , revenue estimates, competitive scenario, and sales data. Agriculture Biotechnology value chain, market status, and price trends are explained in detail. Agriculture Biotechnology industry presence across different geographies covers the regions like North America, Europe, Asia-Pacific, Middle East & Africa, and South America. Further, the countries like United States, Canada, Mexico, China, Japan, Korea, India, Australia, Indonesia, Singapore, Germany, United Kingdom, France, Italy, Spain, Russia, Brazil, Argentina, UAE, Saudi Arabia, Turkey and the rest are analyzed in this report.

Enquire For Complete Sample Report Copy Or Request For Customization:

https://www.reportspedia.com/report/life-sciences/global-agriculture-biotechnology-market-research-report-2020-2026-of-major-types,-applications-and-competitive-vendors-in-top-regions-and-countries/54704#inquiry_before_buying

Reasons To Buy This Report:

Agriculture Biotechnology Report Effectively Addresses The Below Queries.

Explore Detailed Table Of Content With Table Of Figures: @

https://www.reportspedia.com/report/life-sciences/global-agriculture-biotechnology-market-research-report-2020-2026-of-major-types,-applications-and-competitive-vendors-in-top-regions-and-countries/54704#table_of_contents

Continued here:
Global Agriculture Biotechnology Market Comprehensive Insights and Global Briefing 2020 to 2026 - Aerospace Journal